Unethical and false presentation of facts’ by Entod Pharmaceuticals on PresVu eye drops, say official sources

The claims made by ENTOD Pharmaceuticals about its product PresVU eye drops being approved by DCGI and offering spectacular treatment for Presbyopia are unethical and false presentation of facts, said a top official source to ANI. Earlier, the company claimed, "PresVu is the first eye drop in India specifically developed to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40. However, medical experts are calling it an "imperfect and temporary solution", "Pilocarpine eye drops have been used for glaucoma treatment since at least 75 years. Dr. Tushar Grover, Associate Consultant, Department of Ophthalmology, Sir Ganga Ram Hospital said, "The drops recently introduced for correction of presbyopia are essentially pilocarpine eye drops at a relatively lower concentration.